Director Kenneth J Kelley sold $241K of Halozyme Therapeutics, Inc.

Sold$240,594

$48.12Price

5,000Shares

−3%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Mon, Feb 1. Filed Mon, Feb 1, 1:56 PM ET, during the session. Not investment advice.